Compare ARK Genomic Revolution ETF (ARKG) vs Brunswick Corporation (BC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Brunswick Corporation — how do they compare? ARK Genomic Revolution ETF trades at $41, while Brunswick Corporation trades at $77.8 (market cap $5.06B). The key difference: Brunswick Corporation pays a 2.26% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Brunswick Corporation nearer its low. Which is the better fit depends on your goals.
| ARKG | BC | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $89.22 |
52-Week Low | $23.09 | $56.64 |
Market Cap | — | $5.06B |
Enterprise Value | — | $7.22B |
Dividend Yield | — | 2.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
BC trades at $77.9, down 0.12% on the day, with a bearish technical signal but strong analyst support. The stock shows mixed fundamentals with a high P/E of 73.92 and negative net income margin of -2.47%, though revenue remains stable near $5.4 billion. Recent news highlights operational updates and expansion milestones, including Freedom Boat Club's 450th location opening (GlobeNewsWire, June 23, 2026).
Outlook is cautiously optimistic given the 71% buy rating from analysts and an $86.40 consensus price target, but risks include persistent negative profitability and high debt levels. The upcoming Q2 2026 earnings report on July 30, 2026 (GlobeNewsWire, July 9, 2026) will be critical for confirming turnaround potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Brunswick Corporation
Brunswick Corp is the leader in several recreational sectors. The firm is the leading boat manufacturer, and its brands include Mercury and Mariner outboard engines
Read more on BC →
